Management of acute steroid-resistant rejection after liver transplantation

World Journal of Surgery

Volumn 20, Issue 8, 1996, Pages 1052-1059

  Platz, Klaus Peter ^a   Mueller, Andrea R ^a   Zytowski, Michael ^a   Lemmens, Peter ^a   Lobeck, Hartmut ^a   Neuhaus, Peter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; GANCICLOVIR; INOLIMOMAB; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; OKT 3; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE KIDNEY FAILURE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG CHOICE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; NEUROLOGICAL COMPLICATION; ORAL DRUG ADMINISTRATION; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

ACUTE DISEASE; CAUSE OF DEATH; CYCLOSPORINE; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY FAILURE, ACUTE; LIVER TRANSPLANTATION; METHYLPREDNISOLONE; MUROMONAB-CD3; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TACROLIMUS;

EID: 0029773839     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900160     Document Type: Conference Paper

References (26)

1. Williams, J.W., Vera, S.R., Peters, T.G., van Voorst, S.: Survival following hepatic transplantation in the cyclosporine era. Am Surg. 52:291, 1986
2. Klompmaker, I.J., Haagsma, E.B., Gouw, A.S., Verver, R., Sloof, M.J.: Azathioprine and prednisolone immunosuppression versus maintenance triple therapy including cyclosporine for orthotopic liver transplantation. Transplantation 48:814, 1989
3. Iwatsuki, S., Starzl, T.E., Todo, S., et al.: Experience in 1000 liver transplants under cyclosporine and steroids immunosuppression. Transplant. Proc. 20:498, 1988
4. Ford, H.R., Fryd, D.S., Canafax, D.M., et al.: Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine. Transplant. Proc. 20:8, 1988
5. Ascher, N., Stock, P.G., Baumgardner, G.L., Payne, W.D., Najarian, J.S.: Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg. Gynecol. Obstet. 167:474, 1988
6. Starzl, T.E., Todo, S., Fung, J., Demetris, A.J., Venkataremman, R., Jain, A.: FK506 for liver, kidney, and pancreas transplantation. Lancet 2:1000, 1989
7. European FK506 Multicentre Liver Study Group: Randomized trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 344:423, 1994
8. U.S. Multicenter FK506 Liver Study Group: A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N. Engl. J. Med. 337:1110, 1994
9. Swinnwn, L.J., Costanzo-Nordin, M.R., Fisher, S.G., et al.: Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant-recipients. N. Engl. J. Med. 323:1723, 1990
10. Canioni, D., Mac Kelvie, P., Debure, A., Nezolof, C.: Lymphadenopathy in renal transplant patients treated with immunosuppressive antibodies (OKT3 and anti-thymocyte-globulin): a report of nine cases. Am. J. Surg. Pathol. 13:87, 1989
11. Ho, M., Jaffe, R., Miller, G., et al.: The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestation in children. Transplantation 45:719, 1988
12. Abramovicz, D., Schandene, L., Goldmann, L., et al.: Release of tumor necrosis factor, interleukin-2, and gamma interferon inserum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 47:606, 1989
13. Chatenoud, L., Reuter, A., Legendre, C., et al.: Systemic reaction to the anti T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-α. N. Engl. J. Med. 320:1420, 1989
14. Demetris, A.J., Fung, J.J., Todo, S., et al.: Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy: a clinicopathologic study of 96 patients. Transplantation 53:1056, 1992
15. McDiarmid, S.V., Klintmalm, G.B., Busuttil, R.W.: FK506 conversion for intractable rejection of liver allograft. Transpl. Int. 6:305, 1993
16. Winkler, M., Ringe, B., Jost, U., et al.: Conversion from cyclosporin to FK506 after liver transplantation. Transpl. Int. 6:319, 1993
17. Neuhaus, P., Blumhardt, G., Bechstein, W.O., et al.: Comparison of FK506- and cyclosporine A-based immunosuppression in primary orthotopic liver transplantation: a single center experience. Transplantation 59:31, 1995
18. Neuhaus, P., Bechstein, W.O., Blumhardt, G., et al.: Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody. Transplantation 55:1320, 1993
19. Platz, K-P., Mueller, A.R., Blumhardt, G., Bechstein, W.O., Bachmann, S., Neuhaus, P.: Nephrotoxicity after orthotopic liver transplantation: a comparison between cyclosporine A and FK506. Transplantation 58:170, 1994
20. Mueller, A.R., Platz, K-P., Bechstein, W.O., et al.: Neurotoxicity after orthotopic liver transplantation: a comparison between cyclosporine and FK506. Transplantation 58:155, 1994
21. Thomson, A.W.: FK506: profile of an important new immunosuppressant. Transpl. Rev. 4:1, 1990
22. Sigal, N.H., Siekierka, J.J., Dumont, F.J.: Observation on the mechanism of action of FK506: a pharmacological probe of lymphocyte signal transduction. Biochem. Pharmacol. 40:2201, 1990
23. Tocci, M.J., Matkowich, D.A., Collier, K.A., et al.: The immunosuppressant FK506 selectively inhibits expression of early T-cell activation genes. J. Immunol. 143:718, 1989
24. Kay, J.E., Doe, S.E., Benzie, C.R.: The mechanism of action of the new immunosuppressive drug FK506. Cell. Immunol. 124:175, 1989
25. Platz, K-P., Mueller, A.R., Jonas, S., et al.: Toxicity versus rejection - or why conversions between cyclosporine A and FK506 were performed following orthotopic liver transplantation. Clin. Transplant. 9:146, 1995
26. Singh, N., Dummer, J.S., Krusne, S., et al.: Infections with cytomegalovirus and other herpes viruses in 121 liver transplants recipients: transmission by donated organs and the effect of OKT3 antibodies. J. Infect. Dis. 158:124, 1988